# Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)

> **NCT00243178** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 6706 (actual)

## Conditions studied

- Atrial Fibrillation
- Vascular Risk

## Interventions

- **DRUG:** clopidogrel (SR25990C)

## Key facts

- **NCT ID:** NCT00243178
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 6706 (ACTUAL)
- **Last updated:** 2009-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243178, "Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00243178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*